Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:53 PM UTC
| NCT Number | NCT05733715 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | March 24, 2026 (Mar 24, 2026) |
As of July 17, 2026: Clinical trial NCT05733715 is currently recruiting participants. This early_phase1 study for renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05733715 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05733715 was last updated Mar 24, 2026 (March 24, 2026). HelloStudys verifies this status automatically.